Skip to search formSkip to main contentSkip to account menu

Standard Risk Acute Leukemia

Known as: Standard Risk, Standard Risk (MRD <0.05%) 
Acute leukemia patients are stratified into the standard risk group when their minimal residual disease levels are lower than 0.05%.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Acute lymphoblastic leukemia (ALL) is the most common malignancy among children. The trial Chinese Children Leukemia Group (CCLG… 
Highly Cited
2018
Highly Cited
2018
Dana-Farber Cancer Institute (DFCI) ALL Consortium Protocol 05-001 tested a new risk stratification system in children and… 
Highly Cited
2015
Highly Cited
2014
Highly Cited
2014
PURPOSE From 2002 to 2007, the International Berlin-Frankfurt-Münster Study Group conducted a prospective randomized clinical… 
Highly Cited
2010
Highly Cited
2010
The Children's Cancer Group enrolled 13 298 young people age <21 years on 1 of 16 protocols between 1983 and 2002. Outcomes were… 
Highly Cited
2010
Highly Cited
2010
It is estimated that there are 100,000 people living with sickle-cell disease (SCD) in the United States [1]. The most common… 
Highly Cited
2001
Highly Cited
2001
The Dana-Farber Cancer Institute (DFCI) acute lymphoblastic leukemia (ALL) Consortium Protocol 91-01 was designed to improve the… 
Highly Cited
1995
Highly Cited
1995
PURPOSE To assess the effect of treatment intensification and that of extended intrathecal methotrexate substitution for cranial… 
Highly Cited
1994
Highly Cited
1994
PURPOSE The goals of this treatment program were as follows: to improve event-free survival (EFS) rates for high-risk (HR… 
Highly Cited
1987
Highly Cited
1987
Six hundred and fifty‐six children with acute lymphoblastic leukemia (ALL) have been diagnosed in the five Nordic countries…